| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | GW843682X | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.004 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.1 | 0.2 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.05 |